Expanding Cell & Gene Therapy Access Requires More Than Science (Broadcast 1)

Biotech, Cell and Gene Therapy, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • Thursday, October 15, 2026 | 1pm EDT / 12pm CDT / 10am PDT
  • 60 min

As cell and gene therapies continue to mature, the industry is increasingly focused on a critical question: how can access expand while preserving the specialized care and coordination these therapies require?

Historically, treatment has been concentrated within a limited number of specialized centers. However, growing patient populations, expanding therapeutic areas, geographic barriers and long-term sustainability considerations are driving new approaches to care delivery.

This webinar will explore how emerging delivery models, including connected care networks and greater community integration, may help broaden access to advanced therapies. The featured speakers will discuss the opportunities and challenges associated with creating more flexible care pathways and support for patients while maintaining quality and safety.

The conversation will highlight the patient perspective, examining how factors such as travel burden, care coordination and access to local resources can influence the treatment experience. Through a forward-looking discussion, attendees will gain insight into how the CGT ecosystem may evolve to support broader access in the years ahead.

Register for this webinar to learn how a new care model may expand cell and gene therapy access while preserving specialized care, safety and patient support.

3-part Cell & Gene Therapy Webinar Series:

Speakers

Kim Tedesco, RPh, Director of Gene & Cell Therapy Pharmacy Operations, Walgreens Gene & Cell Services

Kim Tedesco, RPh, Director of Gene & Cell Therapy Pharmacy Operations, Walgreens Gene & Cell Services

Kim Tedesco, RPh, is the Director of Gene & Cell Therapy Pharmacy Operations at Walgreens Gene & Cell Services Pharmacy. She is a pharmacy leader dedicated to advancing pharmacy practice.

In her current role, Kim leads the strategic direction of the gene and cell pharmacy at Walgreens to create a center of excellence dedicated to gene and cell therapies. She works to overcome barriers and help ensure these new-to-market therapies reach the intended patients.

Kim has previous experience in retail, pharmaceutical sales, operations and specialty pharmacy. She is a licensed Pharmacist in 26 states and attended Duquesne University School of Pharmacy in Pittsburgh, Pennsylvania.

Message Presenter
Elias Zapantis, PharmD, MSPharm, MBA, VP, Central Specialty Operations & Business Transformation, Walgreens Gene & Cell Services

Elias Zapantis, PharmD, MSPharm, MBA, VP, Central Specialty Operations & Business Transformation, Walgreens Gene & Cell Services

Elias Zapantis, PharmD, MS Pharm, MBA, serves as Vice President of Central Specialty Operations and Specialty Business Transformation for Walgreens Specialty Pharmacy. In this role, he leads the strategy, execution and operational performance of Walgreens’ central specialty pharmacy division, with responsibility for advancing scalable, high-quality patient support and service delivery across the enterprise.

Elias is focused on driving specialty pharmacy transformation through operational excellence, process innovation and cross-functional execution. He leads the development and implementation of systems, programs and capabilities that strengthen performance, improve efficiency and support Walgreens’ broader specialty pharmacy growth strategy.

With a patient-centered approach, Elias works to enhance the specialty pharmacy experience by improving access, engagement, clinical coordination and service consistency. He partners across the Walgreens organization to deliver measurable improvements in quality, outcomes and operational effectiveness while positioning Walgreens Specialty Pharmacy for continued growth and innovation.

Message Presenter
Seth Ginsberg, President, Global Healthy Living Foundation

Seth Ginsberg, President, Global Healthy Living Foundation

Seth Ginsberg is an International Health Advocate and thought leader based in New York City. Ginsberg was diagnosed in 1994 with spondylarthritis and in 1999, at age 18, he helped pioneer the world’s first online patient community for the millions of people worldwide suffering from arthritis, called CreakyJoints. CreakyJoints has grown into a trusted and recognized website and patient community, delivering robust patient education, community-based and web-based support, advocacy initiatives and patient-centered research. In 2007, Ginsberg and social entrepreneur Louis Tharp co-founded the Global Healthy Living Foundation (GHLF), the 501(c)(3) non-profit parent organization of CreakyJoints and other advocacy-related activities for neurological and cardiovascular conditions. CreakyJoints Australia, also led by Ginsberg, is the first international patient community under the GHLF umbrella and constitutes a growing and vibrant community of patients throughout Australia.

Read more...


Since 2014, Ginsberg has served as a Principal Investigator of the PCORI-funded patient-powered research network ArthritisPower®. As a web and smartphone app, ArthritisPower is an innovative registry engineered for and by people with rheumatoid arthritis and related autoimmune and inflammatory conditions. Research efforts are overseen by a patient governor group as well as a distinguished research and corporate advisory board.

In 2011, Ginsberg helped create GHLF’s 50-State Network, which is an active network of more than 1,300 patient advocates, based in all 50 states and Puerto Rico. Under Ginsberg’s leadership, the 50-State Network focuses on barriers to care for people living with chronic illness by working with state governors, legislative leadership and insurance commissioners as well as Congress and health-related Congressional Committees and Caucuses, the US Department of Health and Human Services (HHS) and its regulatory agency the Food and Drug Administration (FDA).

Ginsberg appears as a guest on local and national broadcast news programs, is a regular op-ed contributor, healthcare news, opinion and advice columnist for US News & World Report and a frequent keynote speaker at professional conferences and healthcare meetings.

Read Less...

Message Presenter

Who Should Attend?

This webinar will appeal to:

  • Cell and Gene Therapy Manufacturers
  • Commercialization and Market Access Leaders
  • Patient Services and Medical Affairs Professionals
  • Provider and Specialty Pharmacy Partners
  • Consultants and Advisors supporting CGT programs

What You Will Learn

Attendees will gain insight into:

  • Why traditional CGT delivery models are evolving
  • How connected care networks may support expanded access
  • Considerations for balancing specialized expertise with broader reach
  • The role of patient-centered care in future treatment models

Xtalks Partner

Walgreens

Founded in 1901, Walgreens (www.walgreens.com) proudly serves more than 9 million customers and patients each day across its nearly 8,000 stores throughout the U.S. and Puerto Rico. Walgreens has approximately 211,000 team members, including roughly 85,000 healthcare service providers, and is committed to being the first choice for pharmacy, retail and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account